A new study warns that nearly 60% of adults and one-third of children worldwide will be overweight or obese by 2050 unless ...

Receiving an electronic reminder about influenza vaccination appeared to decrease COVID vaccination rates. Further study of ...

In the trial, CagriSema appeared to have a safe and well-tolerated profile. The most common adverse events with CagriSema were gastrointestinal, and the vast majority were mild to moderate and ...

Goldman Sachs has big price targets on two high-yield tobacco stocks. They can provide investors with reliable streams of ...

ISSTA will market direct flights to the capital of Denmark, along with vacation packages and organized tours. Ticket prices ...

Globally, increases in obesity are projected to continue to 2050 for children and adolescents, and the prevalence of overweight and obesity is set to increase among adults.

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

The Wegovy successor was able to meet its primary endpoint with a 15.7% weight loss among those dosed with the combination ...

Novo Nordisk’s vision of 25%-plus weight loss is looking further and further away. | Novo Nordisk’s vision of 25%-plus weight ...

Novo Nordisk shares declined on Monday after the company reported that its next-generation weight-loss drug, CagriSema, ...

MARKS & Spencer has issued final markdowns on its latest sale… and shoppers are racing to nab the bargains.  Stores up and ...

Lego's CEO told AFP that US President Donald Trump's tariff threats do not keep him up at night, as the world's largest toymaker on Tuesday posted record earnings for 2024.